Qi He

518 total citations · 1 hit paper
19 papers, 359 citations indexed

About

Qi He is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Qi He has authored 19 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Rheumatology. Recurrent topics in Qi He's work include Bone Metabolism and Diseases (6 papers), Inflammasome and immune disorders (3 papers) and RNA modifications and cancer (3 papers). Qi He is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Inflammasome and immune disorders (3 papers) and RNA modifications and cancer (3 papers). Qi He collaborates with scholars based in China, United Kingdom and Netherlands. Qi He's co-authors include Haibin Wang, Peng Chen, Gangyu Zhang, Junzheng Yang, Zhaofeng Pan, Shaocong Li, Jiacong Xiao, Zihao Wang, Bai‐Hao Chen and Jiaxu Zeng and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Qi He

18 papers receiving 357 citations

Hit Papers

Biochanin A protects against iron overload associated kne... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi He China 8 226 101 96 59 46 19 359
Enhui Ren China 7 186 0.8× 101 1.0× 76 0.8× 35 0.6× 40 0.9× 14 423
Zhaofeng Pan China 9 255 1.1× 124 1.2× 83 0.9× 93 1.6× 13 0.3× 16 402
Donghao Gan China 9 160 0.7× 40 0.4× 45 0.5× 62 1.1× 83 1.8× 14 344
Zhengzheng Shan China 10 250 1.1× 143 1.4× 39 0.4× 82 1.4× 40 0.9× 25 430
Xiong Qin China 10 243 1.1× 156 1.5× 39 0.4× 41 0.7× 14 0.3× 24 404
Tetsuhiro Horie Japan 14 282 1.2× 85 0.8× 31 0.3× 48 0.8× 51 1.1× 37 459
Shengye Liu China 11 205 0.9× 86 0.9× 32 0.3× 21 0.4× 14 0.3× 22 306
Fábio Alessandro de Freitas Brazil 7 263 1.2× 141 1.4× 202 2.1× 18 0.3× 34 0.7× 15 463
Benzhi Cai China 12 249 1.1× 116 1.1× 20 0.2× 41 0.7× 25 0.5× 18 435
Shengyu Cui China 13 261 1.2× 126 1.2× 21 0.2× 33 0.6× 19 0.4× 31 407

Countries citing papers authored by Qi He

Since Specialization
Citations

This map shows the geographic impact of Qi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi He more than expected).

Fields of papers citing papers by Qi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi He. The network helps show where Qi He may publish in the future.

Co-authorship network of co-authors of Qi He

This figure shows the co-authorship network connecting the top 25 collaborators of Qi He. A scholar is included among the top collaborators of Qi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi He. Qi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
He, Qi, Bai‐Hao Chen, Chuyi Chen, et al.. (2025). Zuogui Pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage. Journal of Ethnopharmacology. 344. 119455–119455. 2 indexed citations
2.
Li, Zepeng, et al.. (2025). METTL3 promotes renal ischemia‐reperfusion injury by modulating miR ‐374b‐5p/ SRSF7 axis. The FASEB Journal. 39(3). e70320–e70320. 1 indexed citations
3.
Xiao, Jiacong, Qi He, Zhaofeng Pan, et al.. (2024). Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis. PLoS ONE. 19(8). e0308731–e0308731. 4 indexed citations
4.
Yang, Kailin, Liuting Zeng, Qi He, et al.. (2024). Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products. Frontiers in Pharmacology. 15. 1250918–1250918. 12 indexed citations
5.
Liao, Mingjun, et al.. (2024). Study on the Mechanism of Xianling Gubao Capsule Regulating Runt-Related Transcription Factor 2 (RUNX2) and Promoting Osteoblast Differentiation by N6-Methyladenosine (m6A) Methyltransferase-Like 3 (METTL3).. PubMed. 2 indexed citations
6.
7.
Li, Shaocong, Qi He, Bai‐Hao Chen, et al.. (2023). Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway. Scientific Reports. 13(1). 13744–13744. 18 indexed citations
8.
Li, Keyi, et al.. (2023). Identification of important genes associated with acute myocardial infarction using multiple cell death patterns. Cellular Signalling. 112. 110921–110921. 7 indexed citations
9.
He, Qi, Dawei Gong, Jiacong Xiao, et al.. (2023). Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway. Journal of Cellular Biochemistry. 124(8). 1155–1172. 4 indexed citations
10.
Li, Miao, Zhaofeng Pan, Qi He, et al.. (2023). Arctiin attenuates iron overload‑induced osteoporosis by regulating the PI3K/Akt pathway. International Journal of Molecular Medicine. 52(5). 6 indexed citations
12.
Chen, Bohao, Qi He, Junzheng Yang, et al.. (2022). Metformin suppresses Oxidative Stress induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Life Sciences. 312. 121092–121092. 36 indexed citations
13.
He, Qi, Junzheng Yang, Delong Chen, et al.. (2022). 12-Deoxyphorbol-13-Hexadecanoate Abrogates OVX-Induced Bone Loss in Mice and Osteoclastogenesis via Inhibiting ROS Level and Regulating RANKL-Mediated NFATc1 Activation. Frontiers in Pharmacology. 13. 899776–899776. 4 indexed citations
14.
He, Qi, Junzheng Yang, Zhaofeng Pan, et al.. (2022). Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis. Biomedicine & Pharmacotherapy. 157. 113915–113915. 149 indexed citations breakdown →
15.
Chen, Delong, Gangyu Zhang, Qingqing Wang, et al.. (2021). 12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation. International Immunopharmacology. 101(Pt A). 108177–108177. 7 indexed citations
16.
Yang, Junzheng, Qi He, Yunhan Wang, et al.. (2021). Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array. Phytomedicine. 94. 153810–153810. 17 indexed citations
17.
He, Qi, Junzheng Yang, Gangyu Zhang, et al.. (2021). Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation. Journal of Ethnopharmacology. 273. 113946–113946. 15 indexed citations
19.
Chen, Peng, Gangyu Zhang, Shan Jiang, et al.. (2021). Mechanosensitive Piezo1 in endothelial cells promotes angiogenesis to support bone fracture repair. Cell Calcium. 97. 102431–102431. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026